Molecular immuno-imaging improves tumor detection in head and neck cancer.
FASEB J.
2022 Jan;36(1):e22092. doi: 10.1096/fj.202100864R. PubMed PMID:
34919761; PubMed Central PMCID:
PMC9584652.
d-mannose suppresses oxidative response and blocks phagocytosis in experimental neuroinflammation.
Proc Natl Acad Sci U S A.
2021 Nov 2;118(44). doi: 10.1073/pnas.2107663118. PubMed PMID:
34702739; PubMed Central PMCID:
PMC8673064.
Highly Efficient Activatable MRI Probe to Sense Myeloperoxidase Activity.
J Med Chem.
2021 May 13;64(9):5874-5885. doi: 10.1021/acs.jmedchem.1c00038. Epub 2021 May 4. PubMed PMID:
33945286; PubMed Central PMCID:
PMC8564765.
A versatile imaging platform with fluorescence and CT imaging capabilities that detects myeloperoxidase activity and inflammation at different scales.
Theranostics.
2019;9(25):7525-7536. doi: 10.7150/thno.36264. eCollection 2019. PubMed PMID:
31695784; PubMed Central PMCID:
PMC6831463.
Myeloperoxidase Molecular MRI Reveals Synergistic Combination Therapy in Murine Experimental Autoimmune Neuroinflammation.
Radiology.
2019 Oct;293(1):158-165. doi: 10.1148/radiol.2019182492. Epub 2019 Sep 3. PubMed PMID:
31478802; PubMed Central PMCID:
PMC6776885.
An activatable PET imaging radioprobe is a dynamic reporter of myeloperoxidase activity in vivo.
Proc Natl Acad Sci U S A.
2019 Jun 11;116(24):11966-11971. doi: 10.1073/pnas.1818434116. Epub 2019 May 23. PubMed PMID:
31123149; PubMed Central PMCID:
PMC6575581.
MRI of Iron Oxide Nanoparticles and Myeloperoxidase Activity Links Inflammation to Brain Edema in Experimental Cerebral Malaria.
Radiology.
2019 Feb;290(2):359-367. doi: 10.1148/radiol.2018181051. Epub 2018 Dec 4. PubMed PMID:
30615566.
Molecular MR Imaging of Myeloperoxidase Distinguishes Steatosis from Steatohepatitis in Nonalcoholic Fatty Liver Disease.
Radiology.
2017 Aug;284(2):390-400. doi: 10.1148/radiol.2017160588. Epub 2017 Mar 30. PubMed PMID:
28358240; PubMed Central PMCID:
PMC5548451.
Myeloperoxidase Nuclear Imaging for Epileptogenesis.
Radiology.
2017 Feb;282(2):614. doi: 10.1148/radiol.2017164044. PubMed PMID:
28099101; PubMed Central PMCID:
PMC7006801.
Polyglucose nanoparticles with renal elimination and macrophage avidity facilitate PET imaging in ischaemic heart disease.
Nat Commun.
2017 Jan 16;8:14064. doi: 10.1038/ncomms14064. PubMed PMID:
28091604; PubMed Central PMCID:
PMC5241815.
Surface biotinylation of cytotoxic T lymphocytes for in vivo tracking of tumor immunotherapy in murine models.
Cancer Immunol Immunother.
2016 Dec;65(12):1545-1554. doi: 10.1007/s00262-016-1911-9. Epub 2016 Oct 8. PubMed PMID:
27722909; PubMed Central PMCID:
PMC5101144.
Myeloperoxidase Nuclear Imaging for Epileptogenesis.
Radiology.
2016 Mar;278(3):822-30. doi: 10.1148/radiol.2015141922. Epub 2015 Sep 23. PubMed PMID:
26397127; PubMed Central PMCID:
PMC4770943.
Gelsolin decreases actin toxicity and inflammation in murine multiple sclerosis.
J Neuroimmunol.
2015 Oct 15;287:36-42. doi: 10.1016/j.jneuroim.2015.08.006. Epub 2015 Aug 9. PubMed PMID:
26439960; PubMed Central PMCID:
PMC4595933.
Identification of cinnabarinic acid as a novel endogenous aryl hydrocarbon receptor ligand that drives IL-22 production.
PLoS One.
2014;9(2):e87877. doi: 10.1371/journal.pone.0087877. eCollection 2014. PubMed PMID:
24498387; PubMed Central PMCID:
PMC3912126.
Synthesis and evaluation of human phosphodiesterases (PDE) 5 inhibitor analogs as trypanosomal PDE inhibitors. Part 2. Tadalafil analogs.
Bioorg Med Chem Lett.
2012 Apr 1;22(7):2582-4. doi: 10.1016/j.bmcl.2012.01.118. Epub 2012 Feb 9. PubMed PMID:
22377518; PubMed Central PMCID:
PMC3307956.
Synthesis and evaluation of human phosphodiesterases (PDE) 5 inhibitor analogs as trypanosomal PDE inhibitors. Part 1. Sildenafil analogs.
Bioorg Med Chem Lett.
2012 Apr 1;22(7):2579-81. doi: 10.1016/j.bmcl.2012.01.119. Epub 2012 Feb 9. PubMed PMID:
22370268; PubMed Central PMCID:
PMC3307826.
Pharmacological validation of Trypanosoma brucei phosphodiesterases B1 and B2 as druggable targets for African sleeping sickness.
J Med Chem.
2011 Dec 8;54(23):8188-94. doi: 10.1021/jm201148s. Epub 2011 Nov 8. PubMed PMID:
22023548; PubMed Central PMCID:
PMC3228873.
Inhibition of HSP90 with pochoximes: SAR and structure-based insights.
Chembiochem.
2009 Nov 23;10(17):2753-9. doi: 10.1002/cbic.200900494. PubMed PMID:
19856365; PubMed Central PMCID:
PMC7556317.
Synthesis of pochoxime prodrugs as potent HSP90 inhibitors.
Bioorg Med Chem Lett.
2009 Jul 15;19(14):3836-40. doi: 10.1016/j.bmcl.2009.04.030. Epub 2009 Apr 17. PubMed PMID:
19410458.
Divergent synthesis of a pochonin library targeting HSP90 and in vivo efficacy of an identified inhibitor.
Angew Chem Int Ed Engl.
2008;47(23):4432-5. doi: 10.1002/anie.200800233. PubMed PMID:
18435518; PubMed Central PMCID:
PMC2701509.
Synthetic study of 1,3-butadiene-based IMDA approach to construct a [5-7-6] tricyclic core and its application to the total synthesis of C8-epi-guanacastepene O.
J Org Chem.
2006 Sep 1;71(18):6892-7. doi: 10.1021/jo060996h. PubMed PMID:
16930042.
Linear C2-Symmetric Polycyclic Benzodithiophene: Efficient, Highly Diversified Approaches and the Optical Properties.
Tetrahedron. Lett.. 2005 November; 46(47):8153-8157. doi: 10.1016/j.tetlet.2005.09.107.
A Novel Thiourea Ligand Applied in the Pd-Catalyzed Heck, Suzuki and Suzuki Carbonylative Reactions.
Adv. Synth. & Catal.. 2004 December; 346(13-15):1669-1673. doi: 10.1002/adsc.200404165.
Synthesis of a novel C2-symmetric thiourea and its application in the Pd-catalyzed cross-coupling reactions with arenediazonium salts under aerobic conditions.
Org Lett.
2004 Jan 22;6(2):221-4. doi: 10.1021/ol036182u. PubMed PMID:
14723533.
Development of Thiourea-based Ligands for the Palladium-Catalyzed Bis-(methoxycarbonylation) of Terminal Olefins.
Eur. J. Org. Chem. 2003, 4346-4348.. 2003 November; 2003(22):4346-4348. doi: 10.1002/ejoc.200300543.
. NIHMSID: NIHMS1842302.
D-mannose suppresses oxidative response and blocks phagocytosis in experimental neuroinflammation.
Proceedings of the National Academy of Sciences of the United States of America. . NIHMSID: NIHMS1842291.
What would you like to do?